Rathod IS - Search Results

1

Design, synthesis and antihistaminic (H1)activity of some condensed 2-(substituted)arylaminoethylpyrimidin-4(3H)-ones.

Shishoo CJ, Shirsath VS, Rathod IS, Patil MJ, Bhargava SS. Shishoo CJ, et al. Among authors: rathod is. Arzneimittelforschung. 2001;51(3):221-31. doi: 10.1055/s-0031-1300028. Arzneimittelforschung. 2001. PMID: 11304938

2

Synthesis and pharmacological study of antihyperlipaemic activity of 2-substituted thieno(2,3-d)pyrimidin-4(3H)-ones.

Shishoo CJ, Devani MB, Bhadti VS, Jain KS, Rathod IS, Goyal RK, Gandhi TP, Patel RB, Naik SR. Shishoo CJ, et al. Among authors: rathod is. Arzneimittelforschung. 1990 May;40(5):567-72. Arzneimittelforschung. 1990. PMID: 2383297

3

Synthesis and quantitative structure-activity relationships of antihyperlipaemic 2-substituted thieno[3,2-d]pyrimidin-4(3H)-ones.

Shishoo CJ, Jain KS, Rathod IS, Thakkar BJ, Brahmbhatt SB, Gandhi TP, Bangaru R, Goyal RK. Shishoo CJ, et al. Among authors: rathod is. Arzneimittelforschung. 1996 Mar;46(3):273-6. Arzneimittelforschung. 1996. PMID: 8901148

4

Synthesis and QSAR of some 3-amino-2-(substituted)aminomethyl-5,6-disubstituted thieno[2,3-d]pyrimidin-4(3H)-ones as novel H1-receptor antagonists.

Shishoo CJ, Shirsath VS, Rathod IS, Brahmbhatt SB, Pathak US, Jain KS. Shishoo CJ, et al. Among authors: rathod is. Drug Des Discov. 1997 Aug;15(2):105-15. Drug Des Discov. 1997. PMID: 9342553

5

Mechanism of the antihyperlipaemic activity and pharmacokinetics of 2-chloromethyl-5,6,7,8-tetrahydrobenzo(b)thieno[2,3-d]pyrimidin-4(3H)-o ne.

Shishoo CJ, Gandhi TR, Rathod IS, Jain KS, Goyal RK. Shishoo CJ, et al. Among authors: rathod is. Arzneimittelforschung. 1997 Oct;47(10):1125-9. Arzneimittelforschung. 1997. PMID: 9368706

6

Design, synthesis and antihistaminic (H(1)) activity of some condensed 3-aminopyrimidin-4(3H)-ones.

Shishoo CJ, Shirsath VS, Rathod IS, Yande VD. Shishoo CJ, et al. Among authors: rathod is. Eur J Med Chem. 2000 Mar;35(3):351-8. doi: 10.1016/s0223-5234(00)00128-8. Eur J Med Chem. 2000. PMID: 10785561

7

Design, synthesis and diuretic activity of some novel 2,4-diamino-6-aryl-7-arylaminopyrimido [4,5-d]pyrimidin-5(6H)-ones.

Rathod IS, Chhabria MT, Chaudhari AS, Jani MH. Rathod IS, et al. Arzneimittelforschung. 2006;56(6):377-81. doi: 10.1055/s-0031-1296737. Arzneimittelforschung. 2006. PMID: 16889118

8

Stability of rifampicin in dissolution medium in presence of isoniazid.

Shishoo CJ, Shah SA, Rathod IS, Savale SS, Kotecha JS, Shah PB. Shishoo CJ, et al. Among authors: rathod is. Int J Pharm. 1999 Nov 10;190(1):109-23. doi: 10.1016/s0378-5173(99)00286-0. Int J Pharm. 1999. PMID: 10528103

9

Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation.

Shishoo CJ, Shah SA, Rathod IS, Savale SS, Vora MJ. Shishoo CJ, et al. Among authors: rathod is. Int J Pharm. 2001 Oct 9;228(1-2):53-67. doi: 10.1016/s0378-5173(01)00831-6. Int J Pharm. 2001. PMID: 11576768 Clinical Trial.

10

Estimation of individual sennosides in plant materials and marketed formulations by an HPTLC method.

Shah SA, Ravishankara MN, Nirmal A, Shishoo CJ, Rathod IS, Suhagia BN. Shah SA, et al. Among authors: rathod is. J Pharm Pharmacol. 2000 Apr;52(4):445-9. doi: 10.1211/0022357001774066. J Pharm Pharmacol. 2000. PMID: 10813557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters